Thomas Berg

Has grant

Head of Division

Heart Center Leipzig at University of Leipzig

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Thomas Berg is the Head of Division at Leipzig University Medical Center, located in Leipzig, Germany. His research interests are focused on hepatology, particularly in areas such as liver cancer detection, transplantation medicine, and chronic hepatitis management. Recent articles authored by him examine clonal hematopoiesis in liver conditions, multimarker algorithms for HCC detection, and the safety and efficacy of Tenofovir Alafenamide in real-world settings.

Recent Grants

Grant: Close

LiSyM Cancer

Open Date: 2021-07-01

Close Date: 2023-06-01

Grant: Close

NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242

Open Date: 2021-03-01

Close Date: 2026-02-01

Grant: Close

THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B

Open Date: 2020-01-01

Close Date: 2024-01-01

Grant: Close

Evaluation of muscarinic acetylcholine receptors type 3 in the pathogenesis of chronic inflammatory cholangiopathies

Open Date: 2020-01-01

Close Date:

Grant: Close

The role of MBOAT7 in hepatic inflammation: implications for therapy

Open Date: 2018-01-01

Close Date: 2021-12-31

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (2)

Klaus Metzeler

Professor of Translational Hematology

Leipzig University

GERMANY

View details

Florian van Bömmel

Professor of Medicine

University Hospital Leipzig

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Berg

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Comparison of CT-Guided Microwave Ablation of Liver Malignancies with and Without Intra-Arterial Catheter Placement for Contrast Administration

Letter to the Editor: Clonal hematopoiesis in MASLD-associated HCC: Variant burden may matter more than presence

Strong or Weak Consent in Medical Law? Identifying the Values Protected in Transplantation Medicine in Europe

Exploring the effects of serum G-CSF levels in acute-on-chronic liver failure (ACLF): Insights from a post hoc analysis of the GRAFT study

Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies

Prospective Analysis of Safety and Efficacy of Tenofovir Alafenamide Fumarate (TAF) in European Real-World Patients with Chronic Hepatitis B: A Single-Centre Real-Word Cohort Study

Enhancing HCC recurrence prediction after liver transplantation: From DCP plus AFP-L3 model to GALAD score

Reply to: “A comment on `A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B’”

Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints

Successful hepatitis B and C screening in the health check-up in the German primary care setting

Collaborators (2)

Klaus Metzeler

Florian van Bömmel

Make your next move.